High level of ATAD2 expression was correlated with lymph node metastasis and advanced clinical stage and predicted poor overall survival in ESCC patients, which indicated an oncogenic role of ATAD2 in ESCC. Here, ATAD2 is linked to metastatic malignant neoplasm in the lymph nodes.